Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023

 
Background: Within the complex framework of public health, the increasing prevalence of blood-borne diseases among individuals engaged in intravenous drug use is recognized as a serious emerging concern and an intricate global issue. The convergence of psychoactive substance abuse and transmission of infectious diseases poses a significant challenge to the global health system, thus presenting a need to have a comprehensive understanding of the underlying dynamics. As injectable drug use persists among vulnerable, yet marginalized populations, the risk of bloodborne diseases especially hepatitis C needs thorough exploration. However, there is a lack of research on opioid use and the prevalence of BBDs among PWID in Palestine. This can be attributed to various factors including societal stigma and discrimination, as well as the complexity of sociodemographic characteristics, risk environment, and insufficient public awareness. The study aims to identify the prevalence of BBDs among PWID in governmental treatment and rehabilitation centers between 2019-2023. It also aims to explore the sociodemographic characteristics (age, gender, level of education, socioeconomic status, marital status, and housing) for both opioid IDU and non-IDU and to identify ways to make recommendations to address their unique needs.
Methods: A quantitative study is conducted because the study is based on hypothesis testing and examining the correlation between variables.
Study Design: Retrospective cohort study, collecting data from the past, and follows a descriptive and correlational design, which aims to describe the sociodemographic characteristics, and examine their relationship to increase risk of BBD.
Study Population: All patients seeking treatment in governmental and private settings.
Sample Study: All the patients aged 18-65 who were admitted to treatment at the two governmental treatment settings between 2019-2023. The sample size is 397 participants. This is a  convenient sample due to the sensitive nature of the issue and the related stigma. The data is gathered from the medical files of the patients and the databases in the centers. The data is stored using encryption methods to protect the privacy of the participants. The data will be used solely for academic research purposes and will be handled with utmost confidentiality and in compliance with all relevant data regulations. The data will be analyzed using SPSS v26.
Note: I am working on my master's thesis with the title of "The Prevalence of Bloodborne Diseases among People Who Inject Drugs in Governmental Treatment Centers in Palestine Between 2019-2023". I am in the process of collecting the data, still, I can share no further incomplete information. The defense of the thesis is scheduled for the end of June 2024. So if you accept my participation in the conference I will be proud and honored to share the results and findings of my study. I want to show deep appreciation and gratitude for this opportunity.